(Q38289626)

English

Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

0 references

1 reference

Europe PubMed Central

Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

M Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

A D Purushotham

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

K Horgan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

J M Klaase

4

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

M Douek

5

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

language of work or name

0 references

publication date

16 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

British Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

169-181

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Use of sentinel node biopsy expands.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Internal mammary lymph nodes and sentinel node biopsy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Methods for combining randomized clinical trials: strengths and limitations.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9673

21 January 2018

Identifiers

10.1002/BJS.9673

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38289626&oldid=1752000782"